etidronate has been researched along with Skin Diseases in 6 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with etidronate suppressed this increase." | 6.76 | Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy. ( Furukawa, F; Hata, M; Hattori, M; Ikeda, T; Kaminaka, C; Kanazawa, N; Nishide, T; Ohta, C; Tsujioka, K; Uede, K; Yamamoto, Y, 2011) |
| "Treatment with etidronate suppressed this increase." | 2.76 | Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy. ( Furukawa, F; Hata, M; Hattori, M; Ikeda, T; Kaminaka, C; Kanazawa, N; Nishide, T; Ohta, C; Tsujioka, K; Uede, K; Yamamoto, Y, 2011) |
| "Calciphylaxis is a local tissue calcific reaction at the site of an injection of challenger substance given a critical time period after the oral administration of a sensitizer substance such as dihydrotachysterol (DHT), vitamin D or parathormone." | 1.27 | Cutaneous calciphylactic reactions in the mouse and the rat and the effects of diphosphonates on the reaction in the rat. ( McClure, J; Miller, S; Vernon-Roberts, E, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, F | 1 |
| Kaminaka, C | 1 |
| Ikeda, T | 1 |
| Kanazawa, N | 1 |
| Yamamoto, Y | 1 |
| Ohta, C | 1 |
| Nishide, T | 1 |
| Tsujioka, K | 1 |
| Hattori, M | 1 |
| Uede, K | 1 |
| Hata, M | 1 |
| Neau-Cransac, M | 1 |
| Lepreux, S | 1 |
| Labreze, C | 1 |
| Quinart, A | 1 |
| Revel, P | 1 |
| Saric, J | 1 |
| Bioulac-Sage, P | 1 |
| Miller, S | 1 |
| Vernon-Roberts, E | 1 |
| McClure, J | 1 |
| Merkulov, VK | 1 |
| Taranova, LV | 1 |
| Khozhenko, EV | 1 |
| Matkovskaia, TA | 1 |
| Kolganova, NA | 1 |
| O'Hara, JP | 1 |
| Jowsey, J | 1 |
| Williams, GA | 1 |
| Rabens, SF | 1 |
| Bethune, JE | 1 |
2 trials available for etidronate and Skin Diseases
| Article | Year |
|---|---|
Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; | 2011 |
[Therapeutic efficacy of Ruzam+ cream].
Topics: Anti-Allergic Agents; Anti-Bacterial Agents; Drug Combinations; Etidronic Acid; Humans; Ointments; S | 2000 |
4 other studies available for etidronate and Skin Diseases
| Article | Year |
|---|---|
Uncommon localization of calcinosis cutis after liver transplantation.
Topics: Adult; Bone Density Conservation Agents; Calcinosis; Etidronic Acid; Graft Rejection; Humans; Hyperc | 2005 |
Cutaneous calciphylactic reactions in the mouse and the rat and the effects of diphosphonates on the reaction in the rat.
Topics: Animals; Calcinosis; Calciphylaxis; Chlorides; Clodronic Acid; Dihydrotachysterol; Diphosphonates; D | 1984 |
Effects of dichloromethylene diphosphonate, ethane-1-hydroxy-1,1-diphosphonate, and rickets in rats.
Topics: Acetates; Animals; Bone and Bones; Bone Development; Bone Resorption; Calcinosis; Calcium; Diet; Eti | 1975 |
Disodium etidronate therapy for dystrophic cutaneous calcification.
Topics: Abscess; Administration, Oral; Calcinosis; Elbow; Etidronic Acid; Female; Humans; Knee; Middle Aged; | 1975 |